| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.18 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |